-
Mashup Score: 1From Recurrence to Perseverance: Jim's Prostate Cancer Story - 6 hour(s) ago
As a civilian partner working for the Army for many years following his time in Vietnam, Jim didn’t suspect anything was amiss when he went for his annual health exam in 2006. However, during…
Source: newsroom.astellas.usCategories: General Medicine News, PayerTweet
-
Mashup Score: 1PSMA PET as a Biomarker for Advanced Prostate Cancer - Oliver Sartor - 12 hour(s) ago
Program: Beyond Androgen Blockade – New Pathways and Novel Treatments in mHSPC and mCRPC Part of an Independent Medical Education Initiative Supported by LOXO@Lilly Biographies: A. Oliver Sartor, MD, Disease Group Leader GU Cancers, Director of Radiopharmaceutical Trials, Mayo Clinic, Rochester, MN Neal D. Shore, MD, FACS, Medical Director, Carolina Urologic Research Center, Atlantic Urology…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 4Systematic Review Sheds Light on Treatment Intensification in Metastatic Prostate Cancer - Peter Goebell - 2 day(s) ago
Zach Klaassen and Peter Goebell discuss a systematic review focused on treatment intensification for metastatic hormone-sensitive prostate cancer. Dr. Goebell’s study aims to assess if scientific evidence, as outlined in guidelines, translates into real-world practice changes. The review, incorporating data from 344,000 patients globally, examines the application of doublets and triplets in…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 3Translational Regulation in Prostate Cancer: The Akt/mTOR and MNK/eIF4E Pathways Unveiled - Daniela Brina - 2 day(s) ago
Daniela Brina discusses her team’s paper on prostate cancer pathways and the role of myeloid-derived suppressor cells (MDSCs) in tumor progression. The study delves into the extracellular interaction between prostate cancer and MDSCs, employing polysome profiling techniques across different genetic backgrounds. Dr. Brina and her team identified specific ligands and receptors that facilitate the…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 3Prostate Cancer Cell Metabolism Dictates Differentiation and Therapy Response - Andrew Goldstein - 3 day(s) ago
Andrea Miyahira hosts Andrew Goldstein to discuss his group’s research on prostate cancer, published in Nature Cell Biology. Dr. Goldstein, along with his team, including grad students Jenna Giafaglione and Preston Crowell, explores the metabolic processes influencing prostate cancer’s response to anti-androgen treatment. Their study reveals that basal and luminal cells in the prostate have…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 2
Samuel Washington engages with Leanne Woods-Burnham to delve into prostate cancer screening for Black men in the U.S., highlighting their discussion at the SUO conference. Dr. Woods-Burnham emphasizes the decline in localized prostate cancer detection following 2012 guideline changes and a concerning rise in metastatic diagnoses, disproportionately affecting Black men. Despite recommendations…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 12
Michael Morris highlights notable prostate cancer trials, focusing on AMG 509, a bispecific antibody targeting STEAP1 and CD3. This promising early-phase study, still determining optimal dosages, shows potential in treating prostate cancer, a field historically resistant to immune therapy. Dr. Morris emphasizes AMG 509’s ability to reduce bony and visceral diseases, including liver disease, with…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 0‘Paths’ of Treatment Possibilities in Prostate Cancer - 6 day(s) ago
An expert spoke with CURE® about the next steps for patients recently diagnosed with prostate cancer and the types of treatments they may receive.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet
-
Mashup Score: 3Study Reveals African Ancestry Gene Variant Strongly Linked to Highly Aggressive Forms of Prostate Cancer - Mayuko Kanayama - 6 day(s) ago
Andrea Miyahira interviews Mayuko Kanayama about her team’s research on a HOXB13 variant linked to aggressive prostate cancer in African ancestry populations. Published in European Urology, their study focuses on the HOXB13 stop-loss germline variant X285K, prevalent in West African ancestry, including Nigeria, Senegal, and Ghana. This variant, associated with earlier diagnosis and higher…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet-
Study reveals African ancestry gene variant is strongly linked to highly aggressive forms of #ProstateCancer. Mayuko Kanayama, MD, PhD @brady_urology joins @AndreaMiyahira @PCFnews to discuss her team's research on a HOXB13 variant in this discussion > https://t.co/MYGVYnYuNI https://t.co/zzpt0XA7ZD
-
-
Mashup Score: 2The Critical Intersection of Androgen Receptor Pathways and Cell Cycle Regulation in Prostate Cancer Therapy - Rana McKay - 6 day(s) ago
Program: Beyond Androgen Blockade – New Pathways and Novel Treatments in mHSPC and mCRPC Part of an Independent Medical Education Initiative Supported by LOXO@Lilly Biographies: Rana R. McKay, Medical Oncologist, Associate Professor, University of California, San Diego, San Diego, CA Alicia Morgans, MD, MPH , Genitourinary Medical Oncologist, Medical Director of Survivorship Program at…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
Jim, who has been living with #ProstateCancer on and off for 15+ years, shares his story in the hope of inspiring and educating others navigating a prostate cancer diagnosis of their own: https://t.co/E05h7DXnht https://t.co/wTXuvs2Unf